Howard Capital Management (New York)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Howard Capital Management (New York)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$24.6M	Sell	175,004 -1,851	-1%	-$237K	2.76%	13
2020 Q3	$19.7M	Buy	176,855 +1,155	+0.7%	+$129K	2.49%	16
2020 Q2	$19.7M	Buy	175,700 +760	+0.4%	+$74.8K	2.62%	11
2020 Q1	$13.5M	Buy	174,940 +2,630	+2%	+$233K	2.31%	17
2019 Q4	$16.4M	Buy	172,310 +27,470	+19%	+$2.38M	2.05%	19
2019 Q3	$11M	Buy	144,840 +7,900	+6%	+$657K	1.57%	30
2019 Q2	$12M	Buy	136,940 +10,102	+8%	+$862K	1.64%	31
2019 Q1	$11.5M	Buy	126,838 +44,611	+54%	+$3.8M	1.62%	30
2018 Q4	$5.9M	Sell	82,227 -72,600	-47%	-$5.85M	0.97%	37
2018 Q3	$14.8M	Buy	154,827 +3,780	+3%	+$366K	1.98%	18
2018 Q2	$14.4M	Buy	151,047 +128,065	+557%	+$11.8M	2.07%	20
2018 Q1	$2.02M	Buy	+22,982	New	+$2.1M	0.29%	52
2017 Q3	–	Sell	-3,200	Closed	-$247K	–	113
2017 Q2	$247K	Buy	+3,200	New	+$227K	0.04%	103

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Howard Capital Management (New York)'s XBI Position: Q4 2020 in Review

Howard Capital Management (New York) reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1% in Q4 2020, selling an estimated $237K and leaving 175,004 shares worth $24.6M. The position accounts for 2.76% of the portfolio, ranked #13.

Howard Capital Management (New York) first reported a position in XBI in Q2 2017 and has held it in 13 quarters since. 654 funds tracked by Wall St. Rank hold XBI as of Q4 2020.

Howard Capital Management (New York) held 175,004 shares of State Street SPDR S&P Biotech ETF worth $24.6M as of Q4 2020.
Howard Capital Management (New York) sold 1,851 State Street SPDR S&P Biotech ETF shares in Q4 2020, an estimated $237K.
State Street SPDR S&P Biotech ETF made up 2.76% of Howard Capital Management (New York)'s portfolio in Q4 2020, its #13 holding.
Howard Capital Management (New York) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and has held it in 13 quarters since.
654 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2020.

Based on Howard Capital Management (New York)'s 13F filing for Q4 2020, filed 2 Feb 2021.